Cargando…

Collaboration between Family Physicians and Specialists in the Diagnosis and Management of Familial Hypercholesterolemia

Detalles Bibliográficos
Autor principal:	Kotani, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University Wonju College of Medicine 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430315/ https://www.ncbi.nlm.nih.gov/pubmed/34549032 http://dx.doi.org/10.15280/jlm.2021.11.2.94

Ejemplares similares

The Necessity of Collaboration With Doctors Involved in Annual Medical Checkups in the Identification of Familial Hypercholesterolemia in Japan
por: Kakehi, Eiichi, et al.
Publicado: (2022)

Cutaneous Xanthomas in a Young Child: Familial Hypercholesterolemia
por: Kumar, Sawan, et al.
Publicado: (2017)

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

General Physicians or Specialists?
por: Chataway, Jeremy
Publicado: (1995)

More General Physicians or Specialists?
por: Bateman, D E
Publicado: (1995)

More General Physicians or Specialists?
por: Levine, David
Publicado: (1995)

More General Physicians or Specialists?
por: Freeman, Anthony G
Publicado: (1995)

Risk of cardiovascular disease with lipoprotein(a) in familial hypercholesterolemia: a review
por: Watanabe, Jun, et al.
Publicado: (2020)

Lipoprotein(a) and Familial Hypercholesterolemia: A Short Review Including the Laboratory Viewpoint
por: Hamasaki, Masato, et al.
Publicado: (2020)

The Family Physician, the Specialist and the Patient
Publicado: (1903)

Familial hypercholesterolemia and statins in the COVID-19 era: Mitigating the risk of ischemic stroke
por: Vuorio, Alpo, et al.
Publicado: (2021)

Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2020)

Familial Hypercholesterolemia: Present and Future Management
por: Sjouke, B., et al.
Publicado: (2011)

Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2021)

LDL apheresis in a woman with severe heterozygous familial hypercholesterolemia. Late, but not too late
por: Mickiewicz, Agnieszka, et al.
Publicado: (2015)

Opportunities for preventing further endothelial dysfunction in pregnant COVID-19 patients with familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2022)

Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management
por: Mytilinaiou, Maria, et al.
Publicado: (2018)

Characterization of coronary atherosclerotic plaques in a homozygous familial hypercholesterolemia visualized by optical coherence tomography
por: Liu, Ze-Sen, et al.
Publicado: (2018)

Gradual dose Titration of Lomitapide may Prevent Therapeutic Delays in Patients with Homozygous Familial Hypercholesterolemia
por: Harada-Shiba, Mariko, et al.
Publicado: (2023)

Genetic Diagnosis of Familial Hypercholesterolemia in Asia
por: Huang, Chin-Chou, et al.
Publicado: (2020)

Molecular diagnosis methods in familial hypercholesterolemia
por: Moldovan, Valeriu, et al.
Publicado: (2020)

Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia
por: McGowan, Mary P., et al.
Publicado: (2019)

Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and Management
por: Najam, Osman, et al.
Publicado: (2015)

Investigating the barriers to teaching family physicians' and specialists' collaboration in the training environment: a qualitative study
por: Beaulieu, Marie-Dominique, et al.
Publicado: (2009)

Patients with familial hypercholesterolemia and COVID-19: Efficient and ongoing cholesterol lowering is paramount for the prevention of acute myocardial infarction
por: Kovanen, Petri T., et al.
Publicado: (2021)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Paediatric dosage ‘need of hours among family physicians/other speciality physicians’
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022)

Should family physicians perform frenotomy for neonatal ankyloglossia?
por: Adragna, Joeseph, et al.
Publicado: (2016)

Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia
por: Ito, Matthew K., et al.
Publicado: (2015)

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
por: Harada-Shiba, Mariko, et al.
Publicado: (2018)

Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol
por: Jones, Laney K., et al.
Publicado: (2022)

Good News: Family Medicine Specialists Have More Opportunity to Diagnose Undiagnosed Sleep Apnea in Children
por: Chidambaram, Ramasamy
Publicado: (2018)

Assessment of family physicians’ awareness and knowledge of familial hypercholesterolemia in governmental hospitals in Riyadh, Saudi Arabia
por: Arnous, Maha Mohammed, et al.
Publicado: (2019)

LDL‐cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid‐lowering therapy
por: Hamasaki, Masato, et al.
Publicado: (2021)

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
por: Tandirerung, Fistra Janrio
Publicado: (2022)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Past, Present, and Future of Familial Hypercholesterolemia Management
por: Rocha, Viviane Z., et al.
Publicado: (2021)

Homozygous familial hypercholesterolemia with an update on cholesterol management
por: Velvet, Anju J J, et al.
Publicado: (2020)

Management of Familial Hypercholesterolemia with Special Emphasis on Evinacumab
por: Krzemińska, Julia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fsf3j86lcj5u7q77k0a9tkc8jn